(Q53969882)

23 May 2018

title

Inadequate therapy and antibiotic resistance. Risk factors for mortality in the intensive care unit. (English)

1 reference

23 May 2018

1 reference

antibiotic resistance

1 reference

1

1 reference

23 May 2018

author name string

José Sifuentes-Osornio

2

1 reference

23 May 2018

Ana Lilia Rolón

3

1 reference

23 May 2018

Gabriela Vázquez

4

1 reference

23 May 2018

Rilke Rosado

5

1 reference

23 May 2018

Mauro Sánchez

6

1 reference

23 May 2018

Juan J Calva

7

1 reference

23 May 2018

Samuel Ponce de León-Rosales

8

1 reference

23 May 2018

publication date

1 May 2002

1 reference

23 May 2018

Archives of Medical Research

published in

1 reference

23 May 2018

volume

33

1 reference

23 May 2018

issue

3

1 reference

23 May 2018

page(s)

290-294

1 reference

23 May 2018

Influence of nosocomial infection on mortality rate in an intensive care unit.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Mortality attributable to nosocomial infections in the ICU

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Risk factors for mortality associated with enterococcal bloodstream infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Risk factors for mortality in Staphylococcus aureus bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Use and Misuse of Antibiotics in Latin America

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

APACHE II: a severity of disease classification system

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Impact of antibiotic resistance on clinical outcomes and the cost of care

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Mortality as an outcome in hospital-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Risk factors for the spread of antibiotic-resistant bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

Increasing prevalence of antimicrobial resistance in intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900380-0

7 January 2021

10.1016/S0188-4409(01)00380-0

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018